Cell No. : Cell Name
RCB2083 : 141-LCL
update : 2026/03/27
|
| Comment | Human B cells transformed by Epstein-Barr virus. RCB2541 was derived from the same patient. TKG0611 (Deposited from Tohoku Univ.). |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Obinata, Masuo
|
| Year of deposit |
2005
|
| Original cell |
TKG0611
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Tissue |
peripheral blood
|
| Disease name |
EBV-transformed lymphoblast cell
|
| Classification |
transformed
|
| History |
Cell Resource Center for Biomedical Research, Tohoku University（TKG00611）
|
|
Lifespan |
infinite
|
| Morphology |
lymphocyte-like
|
| SDS |
SDS_DMSO(Japanese) 
|
| Cellosaurus(Expasy) |
CVCL_6752
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Suspension cells
|
| Culture method |
|
General Guidelines for Culturing Suspension Cells
浮遊細胞の培養に関する一般的な注意(Japanese)
|
| Culture medium |
|
RPMI1640 + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
dilution
|
Culture information
|
Passage ratio |
|
1 : 10 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| Virus (HIV) |
|
LT 400
|
| Virus (HTLV-1) |
|
(-)
|
| Isozyme |
|
LD, NP
|
| STR(human) |
|
OK
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
0
|
| User's Publication |
3
|
| User's Publication |
|
24035
Kondo Y, Yano H, Fujiwara Y, Niino D, Kawano Y, Yasunaga JI, Yamamoto M, Komohara Y.
Scavenger receptor class B type I (SR-BI) as a potential therapeutic target in multiple myeloma.
Med Mol Morphol
2026
PubMed ID: 42268310
DOI: 10.1007/s00795-026-00466-2
|
|
16945
Yano H, Fujiwara Y, Horlad H, Pan C, Kai K, Niino D, Ohsawa K, Higashi M, Nosaka K, Okuno Y, Tamaru JI, Mukasa A, Matsuoka M, Komohara Y.
Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy
Cancer Sci
2022
113(6):2129-2143
PubMed ID: 35343027
DOI: 10.1111/cas.15349
|
|
13994
Horlad H, Ma C, Yano H, Pan C, Ohnishi K, Fujiwara Y, Endo S, Kikukawa Y, Okuno Y, Matsuoka M, Takeya M, Komohara Y.
An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma
Cancer Sci
2016
107(11):1696-1704
PubMed ID: 27564404
DOI: 10.1111/cas.13065
|
Back
Top
CELL BANK Website
